The USDA has conditionally licensed an oral vaccine designed to limit the spread of Borrelia burgdorferi, the bacterium that causes Lyme disease.
The results of a randomized clinical trial in Slovenia suggest that a 7-day course of antibiotics for a rash caused by Lyme disease is noninferior to a 14-day course, researchers reported yesterday in The Lancet Infectious Diseases.
Among the findings: abundant acorns and few predators of rodents help boost tick levels.
